Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
已完结
10
由 静静 发布于 2026/7/20 12:09:52
DOI:10.1016/S1470-2045(21)00027-9
作者：Angela Lamarca,?Daniel H Palmer,?Harpreet Singh Wasan,?Paul J Ross,?Yuk Ting Ma,?Arvind Arora,?Stephen Falk,?Roopinder Gillmore,?Jonathan Wadsley,?Kinnari Patel,?Alan Anthoney,?Anthony Maraveyas,?Tim
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/S1470-2045(21)00027-9
作者：Angela Lamarca,?Daniel H Palmer,?Harpreet Singh Wasan,?Paul J Ross,?Yuk Ting Ma,?Arvind Arora,?Stephen Falk,?Roopinder Gillmore,?Jonathan Wadsley,?Kinnari Patel,?Alan Anthoney,?Anthony Maraveyas,?Tim
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/S1470-2045(21)00027-9
Elsevier
其它数据库
京公网安备 11010802042870号
